Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03683797 · ClinicalTrials.gov registry record · NA
Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 3,267
- Enrollment target
NCT03683797: Completed NA study, sponsored by NYU Langone Health.
NCT03683797 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 3,267 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (133% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03683797, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,267 participants
- Enrollment target
Study Summary
NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.
Primary Outcome
Number of patients admitted to a hospital within after being discharged from an earlier hospital stay.
Interventions
- OTHER Post-discharge call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,267 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2019-03-22 |
| Phase | NA |
What the finished NCT03683797 record still lists
NCT03683797 is an interventional study that assigns participants to a tested intervention. Its 3,267 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (133% higher).
The record links to 0 conditions, and to 1 intervention - of which Post-discharge call is the first listed.
NCT03683797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03683797 about?
NCT03683797 is a clinical study titled "Testing the Efficacy of a Post-discharge Call Program on the Rate of Readmission". NYU Langone Health patients receive a call from a clinical care coordinator after they are discharged from the hospital (within 1-3 days). The current study is testing the efficacy of this program.
What is the current status of trial NCT03683797?
This trial is currently completed. It is a NA study. The enrollment target is 3,267 participants. The study started on 2018-08-13. Estimated completion is 2019-03-22.
What interventions are being tested in trial NCT03683797?
The interventions under investigation include: Post-discharge call (OTHER).
Who is sponsoring clinical trial NCT03683797?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03683797's enrollment target sits among peer trials
3,267 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077762 · 3,266 participants · NA
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)
- NCT06953375 · 3,250 participants · NA
Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI